The risk for inflammatory bowel disease is higher in patients with psoriasis or ankylosing spondylitis using IL-17A inhibitors than in those using apremilast, necessitating careful patient monitoring.

A financial services provider and a leader among foreign bank stocks are standing out this week in the IBD 50. Their charts ...

Finding winning growth stocks can be challenging but the IBD Big Cap 20 screen finds top-notch names. T-Mobile stock made the ...